Our advanced molecular diagnostic panel rapidly and precisely identifies the pathogens responsible for pneumonia. By targeting a broad range of bacteria, viruses, and fungi, it delivers clinically actionable insights that support informed decision-making and tailored treatment strategies.

A comprehensive molecular assay designed to detect a wide range of respiratory pathogens with speed and accuracy. It enables timely and precise diagnosis of conditions such as bronchitis, bronchiolitis, and pneumonia, supporting prompt and targeted clinical management.

An advanced molecular testing solution designed for rapid and reliable detection of COVID-19 and influenza viruses. It accurately differentiates between SARS-CoV-2 and multiple influenza strains, enabling appropriate clinical care and informed public health response.

A sophisticated molecular diagnostic panel developed for the accurate detection of gastrointestinal infections. By identifying bacterial, viral, and parasitic pathogens with high precision, it supports timely diagnosis and targeted therapeutic interventions.

A specialized molecular diagnostic panel designed for the rapid and accurate detection of urinary tract infections. It delivers precise results that support timely diagnosis and guide the appropriate selection of antibiotic therapy.

An innovative molecular diagnostic solution designed to uncover the underlying causes of chronic or non-healing wounds. By accurately detecting bacterial and fungal pathogens, it supports informed clinical decisions, targeted antimicrobial therapy, and optimized wound management strategies.